Aiginger P, Kolbe H, Kühböck J, Spona J
Acta Med Austriaca. 1978;5(4-5):159-61.
The diagnostic value of the serum tumour markers, beta-HCG and AFP, is investigated in 71 patients with malignant testicular tumours. Regular screening with beta-HCG and AFP, has improved the early diagnosis of recurrences and metastases in nonseminomatous testicular tumours.
对71例恶性睾丸肿瘤患者研究了血清肿瘤标志物β-人绒毛膜促性腺激素（β-HCG）和甲胎蛋白（AFP）的诊断价值。采用β-HCG和AFP进行定期筛查，改善了非精原细胞瘤性睾丸肿瘤复发和转移的早期诊断。
